Scalzulli PR - Search Results

1

A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin's lymphoma.

Gaudio F, Loseto G, Bozzoli V, Scalzulli PR, Mazzone AM, Tonialini L, Fesce V, Quintana G, De Santis G, Masciopinto P, Arcuti E, Clemente F, Scardino S, Tarantini G, Pastore D, Melillo L, Pavone V, Maggi A, Carella AM, Di Renzo N, Guarini A, Musto P. Gaudio F, et al. Among authors: scalzulli pr. Ann Hematol. 2023 Feb;102(2):385-392. doi: 10.1007/s00277-023-05100-0. Epub 2023 Jan 16. Ann Hematol. 2023. PMID: 36645458

2

Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report.

Sajeva MR, Greco MM, Cascavilla N, D'Arena G, Scalzulli P, Melillo L, Minervini MM, Bonini A, Di Mauro L, Carotenuto M, Musto P. Sajeva MR, et al. Bone Marrow Transplant. 1996 Jul;18(1):225-7. Bone Marrow Transplant. 1996. PMID: 8832022

3

All-trans retinoic acid in combination with alpha-interferon and dexamethasone for advanced multiple myeloma.

Musto P, Sajeva MR, Sanpaolo G, D'Arena G, Scalzulli PR, Carotenuto M. Musto P, et al. Among authors: scalzulli pr. Haematologica. 1997 May-Jun;82(3):354-6. Haematologica. 1997. PMID: 9234591 Clinical Trial.

4

Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignancies.

D'Arena G, Musto P, Di Mauro L, Cascavilla N, Iacono ND, Scalzulli PR, Matera R, Carotenuto M. D'Arena G, et al. Among authors: scalzulli pr. Am J Hematol. 1998 Aug;58(4):255-62. doi: 10.1002/(sici)1096-8652(199808)58:4<255::aid-ajh1>3.0.co;2-p. Am J Hematol. 1998. PMID: 9692386 Free article.

5

Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.

Musto P, Sanpaolo G, D'Arena G, Scalzulli PR, Matera R, Falcone A, Bodenizza C, Perla G, Carotenuto M. Musto P, et al. Among authors: scalzulli pr. Haematologica. 2001 Jan;86(1):44-51. Haematologica. 2001. PMID: 11146570

6

Pamidronate reduces skeletal events but does not improve progression-free survival in early-stage untreated myeloma: results of a randomized trial.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, Cascavilla N, Melillo L, Scalzulli PR, Dell'Olio M, La Sala A, Mantuano S, Nobile M, Carella AM. Musto P, et al. Among authors: scalzulli pr. Leuk Lymphoma. 2003 Sep;44(9):1545-8. doi: 10.3109/10428190309178778. Leuk Lymphoma. 2003. PMID: 14565658 Clinical Trial.

7

Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, Perla G, Minervini MM, Cascavilla N, Dell'Olio M, La Sala A, Mantuano S, Melillo L, Nobile M, Scalzulli PR, Bisceglia M, Carella AM. Musto P, et al. Among authors: scalzulli pr. Leuk Lymphoma. 2004 Jun;45(6):1219-22. doi: 10.1080/10428190310001641143. Leuk Lymphoma. 2004. PMID: 15360005

8

A reduced intensity conditioning regimen for allografting following autografting is feasible and has strong anti-myeloma activity.

Carella AM, Beltrami G, Corsetti MT, Scalzulli P, Carella AM Jr, Musto P. Carella AM, et al. Haematologica. 2004 Dec;89(12):1534-6. Haematologica. 2004. PMID: 15590410 Clinical Trial.

9

Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes.

Musto P, Lanza F, Balleari E, Grossi A, Falcone A, Sanpaolo G, Bodenizza C, Scalzulli PR, La Sala A, Campioni D, Ghio R, Cascavilla N, Carella AM. Musto P, et al. Among authors: scalzulli pr. Br J Haematol. 2005 Jan;128(2):204-9. doi: 10.1111/j.1365-2141.2004.05288.x. Br J Haematol. 2005. PMID: 15638854 Free article.

10

Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer.

Carella AM, Beltrami G, Corsetti MT, Nati S, Musto P, Scalzulli P, Gonella R, Ballestrero A, Patrone F. Carella AM, et al. Lancet. 2005 Jul 23-29;366(9482):318-20. doi: 10.1016/S0140-6736(05)66989-9. Lancet. 2005. PMID: 16039336 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page